MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23,161 | -4.6% | 30,555 | 0.0% | 0.00% | – |
| Q1 2023 | $24,282 | +101.2% | 30,555 | 0.0% | 0.00% | – |
| Q4 2022 | $12,069 | -71.9% | 30,555 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $43,000 | +16.2% | 30,555 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $37,000 | -58.4% | 30,555 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $89,000 | -34.1% | 30,555 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $135,000 | -39.2% | 30,555 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $222,000 | -24.2% | 30,555 | +1.8% | 0.00% | -33.3% |
| Q2 2021 | $293,000 | -17.5% | 30,000 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $355,000 | +51.1% | 30,000 | 0.0% | 0.01% | +40.0% |
| Q4 2020 | $235,000 | +15.2% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $204,000 | -9.3% | 30,000 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $225,000 | +43.3% | 30,000 | +20.0% | 0.01% | +20.0% |
| Q1 2020 | $157,000 | -30.8% | 25,000 | +66.7% | 0.01% | 0.0% |
| Q4 2019 | $227,000 | +47.4% | 15,000 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $154,000 | -30.3% | 15,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $221,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
| Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
| Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
| Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
| Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
| Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
| Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
| Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |